Next Science Ltd ( (AU:NXS) ) has provided an update.
Next Science Limited has announced that its 2025 Annual General Meeting will take place on Friday, 9 May 2025, at 10:00 am Sydney time. The company has set 19 March 2025 as the deadline for director nomination submissions. This announcement is part of the company’s ongoing efforts to engage with stakeholders and ensure transparent governance practices.
More about Next Science Ltd
Next Science is a medical technology company based in Sydney, Australia, with a research and development center in Florida, USA. Founded in 2012, the company focuses on developing and commercializing its proprietary XBIO™ technology, which effectively reduces biofilm-based infections in human health. The XBIO™ technology is a unique, non-toxic solution that eradicates both biofilm-based and free-floating bacteria, and Next Science holds full patent rights to this intellectual property.
Average Trading Volume: 7,085
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.37M
For a thorough assessment of NXS stock, go to TipRanks’ Stock Analysis page.